Allarity Therapeutics (NASDAQ: ALLR) Stock Plunges Amid Ovarian Cancer Trial Discontinuation
Allarity Therapeutics (NASDAQ: ALLR) stock plummeted over 10% in intraday trading Thursday after the company announced it discontinued its ovarian […]
ALLR